Markets:

Overview

News

Currencies

International

Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

116.81 +2.37 (+2.07%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

36 37 Next >

1 Healthcare Stock Worth Your Attention and 2 Facing Challenges

February 12, 2026

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only...

Via StockStory

Topics Stocks

5 Insightful Analyst Questions From Illumina’s Q4 Earnings Call

February 12, 2026

Illumina’s fourth quarter was marked by strong performance in its clinical consumables business, with management citing 20% year-over-year growth outside China as a key driver. CEO Jacob Thaysen...

Via StockStory

Topics Earnings

10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect

February 10, 2026

Biotech company 10x Genomics (NASDAQ:TXG) will be reporting earnings this Thursday after market hours. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence World Trade

Illumina Inc (NASDAQ:ILMN) Stock Falls Despite Q4 Earnings Beat on Cautious 2026 Outlook ↗

February 05, 2026

Via Chartmill

Topics Earnings

PacBio Earnings: What To Look For From PACB

February 10, 2026

Genomics company Pacific Biosciences of California (NASDAQ:PACB) will be announcing earnings results this Thursday after market hours. Here’s what to expect.

Via StockStory

Topics Artificial Intelligence World Trade

Could Nvidia Be the Best Way to Play the AI Boom in 2026? ↗

February 06, 2026

Nvidia was propelled to its current highs by the development of AI, but is it still one of the best ways to play it?

Via The Motley Fool

Topics Artificial Intelligence

Harvard’s PopEVE AI Cracks the Code of Rare Diseases: Ending the ‘Diagnostic Odyssey’ for Millions

February 06, 2026

In a landmark achievement for computational biology, researchers from Harvard Medical School and the Centre for Genomic Regulation (CRG) have unveiled PopEVE, a groundbreaking artificial intelligence...

Via TokenRing AI

Topics Artificial Intelligence

The Great AI Land Grab: Why Tech Giants are Paying Billions for Talent While Deal Volumes Sink

February 06, 2026

As of February 6, 2026, the technology sector is witnessing a paradoxical shift in the mergers and acquisitions (M&A) landscape. While the sheer number of transactions has hit an eight-year plateau,...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

Molina Healthcare, Coty, Illumina, Amazon And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

February 06, 2026

Via Benzinga

ILMN Q4 Deep Dive: Clinical Consumables Growth, Multiomics Expansion, and Margin Momentum

February 06, 2026

Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 5% year on year to $1.16 billion. The company’s full-year revenue guidance of $4.55 billion...

Via StockStory

Illumina (ILMN) Q4 2025 Earnings Call Transcript ↗

February 05, 2026

Illumina (ILMN) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Illumina (NASDAQ:ILMN) Reports Bullish Q4 CY2025

February 05, 2026

Via StockStory

SBIR Eligibility Requirements: Small Business Qualification Guide Released

February 05, 2026

Via Press Release Distribution Service

Topics Intellectual Property

Cold Chain, High Stakes: A Deep Dive into Azenta’s (AZTA) Life Sciences Transformation

February 05, 2026

Date: February 5, 2026 Introduction In the high-stakes world of life sciences, the "cold chain" is the invisible backbone of modern medicine. From the development of mRNA vaccines to the emerging...

Via Finterra

Topics Artificial Intelligence Earnings Economy

Illumina (ILMN) Reports Q4: Everything You Need To Know Ahead Of Earnings

February 03, 2026

Genomics company Illumina (NASDAQ:ILMN) will be reporting results this Thursday after market close. Here’s what you need to know.

Via StockStory

Topics Artificial Intelligence

The Analyst Verdict: Illumina In The Eyes Of 15 Experts ↗

January 26, 2026

Via Benzinga

The Silicon Ceiling Shatters: S&P 500’s Historic Ascent Past 5,300 and the AI Anchor

January 23, 2026

In a definitive display of market resilience, the S&P 500 (CME:GSPC) achieved a landmark milestone in May 2024, crossing the 5,300 threshold for the first time in history. This surge, culminating in a...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

Here's How Much You Would Have Made Owning Illumina Stock In The Last 20 Years ↗

January 22, 2026

Via Benzinga

Life Sciences Tools & Services Stocks Q3 Teardown: Illumina (NASDAQ:ILMN) Vs The Rest

January 21, 2026

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Illumina (NASDAQ:ILMN) and its peers.

Via StockStory

Topics Artificial Intelligence

Illumina Gets Medicare Boost for Cancer Test, Shares Climb ↗

January 20, 2026

Illumina shares rose after Medicare approved reimbursement for its FDA-approved cancer test, a move expected to drive growth.

Via Benzinga

3 Cash-Producing Stocks with Open Questions

January 18, 2026

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Via StockStory

Topics Artificial Intelligence

3 Inflated Stocks We Approach with Caution

January 15, 2026

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial...

Via StockStory

GRAIL Surges as Canaccord Genuity Sets Ambitious $105 Price Target Following Robust 2025 Growth

January 13, 2026

In a resounding vote of confidence for the future of multi-cancer early detection (MCED), Canaccord Genuity reiterated its "Buy" rating for GRAIL (Nasdaq: GRAL) on Tuesday, January 13, 2026, setting an...

Via MarketMinute

Adaptive Biotechnologies Surges as Preliminary 2025 Results Signal a Turning Point in MRD Commercialization

January 13, 2026

Shares of Adaptive Biotechnologies (NASDAQ: ADPT) soared on Tuesday, January 13, 2026, after the life sciences company announced preliminary fourth-quarter and full-year 2025 financial results that...

Via MarketMinute

From Silicon to Syringes: Nvidia’s AI Dominance Solidified Through Landmark Eli Lilly Alliance

January 12, 2026

In a move that signals the definitive convergence of high-performance computing and biotechnology, NVIDIA Corporation (NASDAQ: NVDA) and Eli Lilly and Company (NYSE: LLY) announced a massive $1 billion...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

How Is The Market Feeling About Illumina Inc? ↗

January 12, 2026

Via Benzinga

AMD Ignites the ‘Yotta-Scale’ Era: Unveiling the Instinct MI400 and Helios AI Infrastructure at CES 2026

January 08, 2026

LAS VEGAS — In a landmark keynote that has redefined the trajectory of high-performance computing, Advanced Micro Devices, Inc. (NASDAQ:AMD) Chair and CEO Dr. Lisa Su took the stage at CES 2026 to...

Via TokenRing AI

Topics Artificial Intelligence Economy

Harvard’s CHIEF AI: The ‘Swiss Army Knife’ of Pathology Achieving 98% Accuracy in Cancer Diagnosis

January 06, 2026

In a landmark achievement for computational medicine, researchers at Harvard Medical School have developed a "generalist" artificial intelligence model that is fundamentally reshaping the landscape of...

Via TokenRing AI

Topics Artificial Intelligence

The Caracas Coup: Markets Surge as 'Weekend Capture' Reshapes Global Energy and Geopolitics

January 06, 2026

The first full trading week of 2026 has opened with a seismic shift in both the geopolitical landscape and the financial markets. Following the dramatic "weekend capture" of Venezuelan President...

Via MarketMinute

Topics Artificial Intelligence Economy Government

1 Profitable Stock to Own for Decades and 2 Facing Challenges

January 04, 2026

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9

...

36 37 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.